Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8093590Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Linked Award Amount
$1.7M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#7,391
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Michael W. Deininger as a PI. Multi-PI records show the full award amount for context.
- 5R01CA268496-02R01The function of MS4A3 in normal and malignant hematopoiesis$592.4Kaward amount
- 5R01CA257602-04R01Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL$358.6Kaward amount
- 5R01CA254354-06R01Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia$358.6Kaward amount
- 3R01CA254354-06S1R01Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia$352.7Kaward amount
Award organization
Organizations that administered FY2024 awards listing Michael W. Deininger as a PI.
FY2024 award administered by Versiti Blood Health, Inc. (WI).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardVersiti Blood Health, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7391
- 2024R01 Grant Holder
- 2025$2M Cumulative Funding